Lynne Fahey McGrath, Director at Alzamend Neuro, Inc. (ALZN), bought 10,000 shares at $0.44 ($4K) on 2023-03-22, disclosed to the SEC on 2023-03-23.
Open-market purchase of $4k ALZN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |